Abstract
care. From population health management perspective, we recommend a systematic approach to adjust the structured care protocol for incompletely-monitored subgroups.
Strenghts and limitations of this study
-The observational real-life design of this study prevented any interference with daily routines of GP practices, thus contributing to good reliability and representativeness of our findings -Because the availability of patient data on age, medication use and diabetes duration allowed to conduct our analyses -in correspondence with professional GP guidelines -for specific HbA1c threshold groups, the findings are relevant and useful for clinical practice -Taking into consideration that a missing registration does not necessarily reflect a lack of care, but might be caused by technical or practical problems instead, the associations found in this study might be underestimated. 
Introduction
Type 2 diabetes is a typical lifestyle-related disease [1] . The course of type 2 diabetes and potential complications are influenced by smoking behavior [2, 3] , BMI [4] and physical exercise [5] . Adopting a healthier lifestyle, e.g. by smoking cessation or weight loss, is known to be very demanding for individual patients [6, 7] . It has been established that attention for non-conscious motivational factors affecting an individual's behavior is important to realise sustained behavioral change [8] . In addition, to avoid relapse [9, 10] and maintain long-term behavioral change, follow-up support for lifestyle-related themes is recommended [11, 12] . Accordingly, guidelines for general practitioners (GPs) emphasize to monitor not only HbA 1c levels, but also the physiological target indicators systolic blood pressure and LDL, as well as lifestyle-related indicators [13, 14] .
However, for an average GP, providing structured primary diabetes care with sufficient attention for both physiological monitoring and lifestyle adaptation [15] is known to be challenging [16] . Therefore, in many Western countries, varying from the US and Europe [17, 18] to New-Zealand [19] , an increasing number of GPs has delegated the regular structured primary diabetes care to nurse practitioners.
It is known that implementing structured primary diabetes care and delegation of tasks to a nurse practitioner has considerable impact on the organization of the GP practice [20, 21] .
For example, in the USA, an evaluation of the recent Comprehensive Primary Care (CPC)
program revealed a need to refine practice workflows, to incorporate new staff roles, and to overcome incompatibility of health technology systems [22] . In the Netherlands, most GPs have joined together in local 'care groups' [23] that provide logistic and quality support to individual GP practices. In addition, collective structured diabetes care protocols are negotiated with local health insurance companies. The agreements between care groups and health insurance companies on structured diabetes care protocols enable GPs to offer high-quality intensive primary diabetes care. To illustrate, on an annual basis, four well as paramedical diabetes care (e.g. annual screening of fundus and feet); participation is free of charge for patients. It is known that providing a structured diabetes care protocol is associated with better monitoring of patients [24] . In addition, adequate registration of the diabetes-related patient health indicators is associated with improvement of the care process [25] .
According to a recent study, care group participation is associated with improvement of the proportion patients with full monitoring of physiological and life style related target indicators [26] . However, a review on chronical care programs in primary care reported that doubts among care providers on the clinical effects of an intervention are a barrier for adoption [27] .
To our knowledge little is known about the relationship between full monitoring of physiological as well as lifestyle related target diabetes indicators in a care group setting and clinical health outcomes. The Hba 1c level is established as a key diabetes health indicator [28] . Therefore, this study aims to investigate the association between full monitoring of 
Research design and methods

Study design and population
Data were used of type 2 diabetes patients from the observational Eerstelijns Zorggroep
Haaglanden (ELZHA) cohort, which is based on primary care registry data from a care group collective in the western part of the Netherlands. In January 2015, the care group numbered 168 GP practices (n=24,459 patients with type 2 diabetes ). On a periodic basis, GP members share an overview of their patient monitoring data with the care group. In February 2017, all GP practices were informed in writing and, based on an opt-out procedure, were invited to participate in this cohort. For the present study, pseudonymized data on monitoring of diabetes target indicators and HbA 1c levels from patients were used from the calendar year 2014. Patients receiving continuously structured primary diabetes care from January 2014 through December 2014 were included. At least one registration of HbA 1c in 2014 was necessary for inclusion. Since systolic blood pressure and LDL guidelines are specified for patients aged ≤80 years, patients aged ≥80 years were excluded. Patients were also excluded in case of missing data on age, gender or disease duration. Finally, because missing data on medication use were partly caused by technical problems, patients without registration of medication prescription were also excluded.
Exposure
Details of the ELZHA cohort study have been described previously (Van Bruggen et al., submitted 
Outcomes
Analysis
Patient and public involvement
Since this study was targeted on a GP supporting approach of structured primary diabetes care, patients were not actively involved.
Ethical considerations
Since the pseudonymized patient data contained only age and gender, the data could be aggregated without enabling investigators to identify individual patients. Due to the high number of patients, informed consent of individual patients was not required.
The study protocol was approved by the Medical Ethical Committee of the Leiden University Medical Center (code G16.102/SH/sh).
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Results
This study included 167 GP practices (99%) with a total of 24,198 patients with type 2 diabetes ; of these, 12,095 patients met the inclusion criteria (for a detailed flowchart of inclusion see Figure 1 ). By definition, in this population HbA 1c was always monitored, as not having an HbA 1c measure available was an exclusion criterion for the present study. Of patients who were incompletely monitored, information on physical exercise was most often missing, followed by smoking, BMI, LDL, and systolic blood pressure ( Figure 2 ).
Characteristics of our study population, classified by HbA 1c profile and monitoring completeness, are presented in Table 1 . Compared to incompletely-monitored patients, fullymonitored patients had lower mean HbA 1c levels in all three HbA 1c profiles. In addition, fullymonitored patients had a longer duration of diabetes than incompletely-monitored patients.
The crude analysis showed that, compared with incompletely-monitored patients, the mean [24] , research on absolute HbA 1c differences is scarce and findings appear to be somewhat inconsistent [29] [30] [31] [32] . Therefore, caution is required when comparing our findings with any earlier studies. However, for each 1% (10.9 mmol/mol) reduction in mean HbA 1c , a significant decrease in health risk has been reported, ranging from 21% for any endpoint related to diabetes including deaths, to 14% for myocardial infarction, and 37% for microvascular complications [33] . Further, our finding that registration of physical exercise was most often lacking, is in line with an earlier small-size study in which only 19% of patients with type 2 diabetes reported 'being guided properly' with regard to physical exercise [34] .
Our finding that, compared with incomplete monitoring, full monitoring of patients is associated with a lower HbA 1c level might be explained by continuity of care in several ways.
First, if patients are monitored at least once a year, an increasing HbA 1c level might be noticed at an early stage, resulting in fast and adequate treatment. Second, periodic monitoring and coaching of patients with regard to weight loss, smoking cessation and physical exercise contributes to enduring lifestyle adaptation [11, 12] , which may lead to lower HbA 1c levels [35] . clinical impact in terms of diabetes-related risks. We recommend a systematic approach to analyzing the needs of incompletely-monitored patient groups, and to adjust the structured care protocol for these subgroups in terms of population health management. 
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Licence
Strenghts and limitations of this study
-The observational real-life design of this study prevented any interference with daily routines of GP practices, thus contributing to good reliability and representativeness of our findings -Because the availability of patient data on age, medication use and diabetes duration allowed to conduct our analyses -in correspondence with professional GP guidelines -for specific HbA1c threshold groups, the findings are relevant and useful for clinical practice -Taking into consideration that a missing registration does not necessarily reflect a lack of care, but might be caused by technical or practical problems instead, the associations found in this study might be underestimated. (8) . In addition, to avoid relapse (9, 10) and maintain long-term behavioural change, follow-up support for lifestyle-related themes is recommended (11, 12) . Accordingly, in the Netherlands, a nationally acknowledged scientific council of general practitioners (GPs) has determined professional guidelines for diabetes primary care (13). ). In correspondence with the NICE guidelines (14) , it is recommended to monitor at least once a year not only HbA 1c levels, but also the biomedical target indicators systolic blood pressure and LDL, as well as lifestyle-related indicators.
However, for an average GP, providing structured primary diabetes care with sufficient attention for both biomedical monitoring and lifestyle adaptation (15) is reported to be challenging (16) . Therefore, in many Western countries, varying from the US and Europe (17, 18) to New-Zealand (19) , an increasing number of GPs has delegated the regular structured primary diabetes care to nurse practitioners.
It is known that implementing structured primary diabetes care and delegation of tasks to a nurse practitioner has considerable impact on the organization of the GP practice (20, 21) .
program revealed a need to refine practice workflows, to incorporate new staff roles, and to overcome incompatibility of health technology systems (22) . To improve the delivery of structured primary diabetes care in the Netherlands, most GPs have joined together in local 'care groups' (23) . Care groups negotiate collective structured diabetes care protocols with the funding institutions of Dutch primary care, namely, local health insurance companies -. protocol. It is known that providing a structured diabetes care protocol is associated with better monitoring of patients (24) . In addition, adequate registration of the diabetes-related patient health indicators is associated with improvement of the care process (25) . The costs of this protocol are fully covered by health insurance companies. For patients, participation is free of charge.
According to a recent study, care group participation is associated with improvement of the proportion patients with full monitoring of biomedical and life style related target indicators (26) . However, a review on chronic care programs in primary care reported that doubts among care providers on the clinical effects of an intervention are a barrier for adoption (27 
Research design and methods
Exposure
Details of the ELZHA cohort study have been described previously (Van Bruggen et al., submitted). In short, within a care group setting, GPs are able to invite all their T2DM patients with primary care treatment for this structured care protocol. During a standard diabetes consultation or at time of diagnosis, patients are informed about this care protocol.
Patients who provide consent to be enrolled, can join the structured primary care protocol.
The protocol includes a quarterly diabetes consultation, in which diabetes-related target indicators are checked and lifestyle education is provided, combined with complementary allied health such as an annual foot check, fundus screening and dietician´s counselling. To facilitate the organization and quality control of this protocol, GP practices receive practical and logistic support, including a computerized system to improve the care process and 
Outcomes
Analysis
For patient characteristics, categorical variables were reported as numbers and percentages. Continuous variables were reported as means with standard deviation (SD) or, when non-normally distributed, as medians with interquartile ranges (IQR). Baseline characteristics of excluded patients were, if available, compared to the study population.
Linear multilevel analyses were conducted to compare HbA 1c levels of fully-monitored and incompletely-monitored patients. Multilevel analyses allowed to adjust the individual observations (level 1) for GP practice (level 2). In addition, the analyses were adjusted for patient age, duration of diabetes and gender, which are relevant possible confounders with regard to HbA 1c outcomes.
Tailored on specific key patient characteristics (age, intensity of medication treatment, and disease duration) professional Dutch GP guidelines recommend differentiated HbA1c targets In view of the relevance for clinical practice, separate multi-level analyses were conducted and reported for each of these HbA 1c profile groups. In addition, in a non-stratified multi-level analysis, we tested whether the magnitude of the effect found in HbA1c profile 2 and 3 differed significantly from Hba1c profile 1. A p-value <0.05 was considered statistically significant; for interaction, a p-value <0.1 was considered statistically significant.
Descriptive statistics were analysed using SPSS, version 24.0. Multilevel analyses were performed using ML WiN (Version 2.28).
Patient and public involvement
Ethical considerations
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Results
This study included 167 GP practices (99%) with a total of 24,198 patients with type 2 diabetes; of these, 12,095 patients met the inclusion criteria (for a detailed flowchart of inclusion see Figure 1 ). By definition, in this population HbA1c was always monitored, as not having an HbA1c measure available was an exclusion criterion for the present study.
Comparing characteristics of the excluded patients (n = 12,103 patients) with the study population (n = 12,095 patients, see supplementary file, table 1), in excluded patients, mean Table 1 . Of patients who were incompletely monitored, information on physical exercise was most often missing, followed by smoking, BMI, LDL, and systolic blood pressure ( Figure   2 ).
Compared to incompletely-monitored patients, fully-monitored patients had lower mean
HbA1c levels in all three HbA1c profiles. In addition, fully-monitored patients had a longer duration of diabetes than incompletely-monitored patients.
The crude analysis showed that, compared with incompletely-monitored patients, the mean 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Discussion
This study explored whether monitoring completeness of biomedical and lifestyle-related diabetes target indicators in a care group setting is associated with HbA 1c level. In all HbA 1c profile groups -defined based on patient age, intensity of medication treatment and disease duration -we found that fully-monitored patients had lower HbA 1c levels than incompletelymonitored patients; the differences ranged from 0.17% (1.89 mmol/mol) to 0.31% (3.36 mmol/mol), indicating that adequate diabetes monitoring of biomedical and lifestyle indicators in primary care is associated with better HbA 1c levels. To our knowledge, this is the first study to analyse the association between systematic diabetes monitoring in primary care and HbA 1c levels. Apart from one longitudinal Dutch study on structured primary diabetes care in a care group setting which reported a sharp decrease in the proportion of patients with a HbA 1c level ≥53 mmol/mol (24), research on absolute HbA 1c differences is scarce and findings appear to be somewhat inconsistent (29) (30) (31) (32) . Therefore, caution is required when comparing our findings with any earlier studies. However, for each 1% (10.9 mmol/mol) reduction in mean HbA 1c , a significant decrease in health risk has been reported, ranging from 21% for any endpoint related to diabetes including deaths, to 14% for myocardial infarction, and 37% for microvascular complications (33) . Further, our finding that registration of physical exercise was most often lacking, is in line with an earlier small-size The present study is characterised by several strengths. First, in our view, an important strength of this study is the design: although randomized clinical trials might help to eliminate bias, adequate powering and generalizability are familiar problems (38) no other relationships or activities that could appear to have influenced the submitted work."
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